Indo Amines (INDOAMIN)₹115.89+0.81%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Indo Amines reported sales of ₹373 Cr, up 30.2% from Jun 2025, and net profit of ₹30.87 Cr, up 6.9% year on year. For the year to Mar 2026, sales were ₹1,156 Cr and net profit ₹78.69 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 252 | 193 | 252 | 264 | 268 | 258 | 284 | 287 | 276 | 276 | 317 | 373 |
| Expenses | 232 | 172 | 235 | 236 | 244 | 233 | 260 | 255 | 244 | 251 | 282 | 321 |
| Operating Profit | 20.02 | 21.02 | 17.02 | 28.02 | 24.03 | 24.01 | 25.03 | 31.01 | 32.04 | 25.03 | 34.06 | 53.02 |
| OPM % | 8.1% | 11.1% | 7.0% | 10.1% | 9.1% | 9.1% | 9.1% | 11.1% | 12.0% | 9.1% | 11.1% | 14.1% |
| Other Income | 4.99 | 1.99 | 4.99 | 7.99 | 4.99 | 1.99 | 0.00 | 15.99 | 4.99 | 1.99 | 5.99 | 0.99 |
| Interest | 6.02 | 6.02 | 5.02 | 5.02 | 6.02 | 6.03 | 6.02 | 6.02 | 6.02 | 6.02 | 6.02 | 6.02 |
| Depreciation | 3.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.02 | 4.01 | 5.02 | 5.02 | 5.02 | 6.02 | 6.02 |
| Profit before tax | 16.02 | 13.02 | 13.02 | 26.05 | 19.02 | 17.04 | 15.02 | 36.02 | 26.04 | 16.02 | 29.06 | 42.04 |
| Tax % | 28.0% | 24.0% | 27.0% | 25.0% | 29.0% | 33.1% | 22.0% | 19.0% | 29.0% | 27.1% | 28.0% | 26.0% |
| Net Profit | 11.96 | 9.97 | 8.96 | 18.92 | 13.95 | 10.97 | 11.96 | 28.89 | 17.93 | 11.96 | 20.92 | 30.87 |
| EPS (Rs) | 1.70 | 1.40 | 1.30 | 2.74 | 1.96 | 1.57 | 1.64 | 3.99 | 2.50 | 1.65 | 2.84 | 4.25 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 252 | 284 | 354 | 526 | 477 | 539 | 783 | 941 | 939 | 1,074 | 1,156 | 1,242 |
| Expenses | 221 | 248 | 313 | 472 | 436 | 477 | 731 | 856 | 861 | 974 | 1,034 | 1,099 |
| Operating Profit | 30.04 | 36.05 | 41.07 | 55.02 | 42.03 | 61.03 | 52.06 | 87.06 | 80.09 | 101 | 123 | 144 |
| OPM % | 12.0% | 13.1% | 12.0% | 10.1% | 9.1% | 11.1% | 7.1% | 9.0% | 8.0% | 9.1% | 11.1% | 11.6% |
| Other Income | 0.99 | 2.99 | 3.99 | 6.99 | 6.99 | 7.99 | 9.99 | 3.99 | 15.99 | 14.98 | 28.96 | 13.96 |
| Interest | 4.02 | 4.01 | 8.03 | 10.03 | 11.04 | 9.03 | 14.05 | 17.05 | 22.08 | 22.09 | 24.07 | 24.08 |
| Depreciation | 12.05 | 12.05 | 12.03 | 15.05 | 20.08 | 11.03 | 14.05 | 17.07 | 15.06 | 17.06 | 21.07 | 22.08 |
| Profit before tax | 15.03 | 23.04 | 25.05 | 38.06 | 18.01 | 49.08 | 35.02 | 57.04 | 58.10 | 77.10 | 106 | 113 |
| Tax % | 38.0% | 29.0% | 36.0% | 34.0% | 30.0% | 23.0% | 33.0% | 28.0% | 26.0% | 27.0% | 25.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 | 0.00 | — |
| Net Profit | 8.97 | 15.94 | 15.94 | 24.93 | 12.95 | 37.84 | 22.92 | 40.88 | 42.82 | 55.82 | 78.69 | 81.68 |
| EPS (Rs) | 1.39 | 2.47 | 2.41 | 3.79 | 1.93 | 5.34 | 3.24 | 5.74 | 6.07 | 7.63 | 10.98 | 11.24 |
| Dividend payout % | 36.1% | 21.0% | 21.0% | 13.0% | 26.0% | 10.0% | 15.1% | 9.0% | 8.0% | 7.0% | 5.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32.91 | 32.95 | 32.93 | 32.92 | 32.92 | 32.94 | 34.92 | 34.94 | 34.95 | 35.94 | 35.94 | 35.94 |
| Reserves | 11.98 | 16.98 | 35.97 | 47.96 | 91.96 | 102 | 127 | 152 | 190 | 228 | 281 | 356 |
| Borrowings | 51.13 | 50.10 | 62.18 | 91.17 | 131 | 143 | 160 | 207 | 233 | 218 | 285 | 312 |
| Other Liabilities | 59.96 | 67.04 | 80.96 | 74.91 | 89.80 | 83.00 | 131 | 160 | 140 | 153 | 177 | 194 |
| Total Liabilities | 155 | 167 | 213 | 246 | 346 | 362 | 453 | 554 | 597 | 635 | 779 | 898 |
| Fixed Assets | 53.12 | 51.10 | 64.16 | 70.22 | 116 | 117 | 125 | 183 | 199 | 210 | 266 | 326 |
| CWIP | 0.99 | 0.00 | 1.99 | 4.98 | 7.96 | 23.90 | 53.77 | 21.90 | 19.93 | 22.92 | 34.89 | 30.87 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 2.99 | 2.99 |
| Other Assets | 102 | 115 | 147 | 171 | 222 | 221 | 274 | 350 | 379 | 401 | 476 | 539 |
| Inventories | 27.02 | 27.02 | 33.01 | 51.98 | 65.98 | 81.99 | 87.99 | 123 | 136 | 114 | 140 | 178 |
| Trade receivables | 39.92 | 45.90 | 60.86 | 73.76 | 113 | 95.70 | 131 | 167 | 187 | 218 | 254 | 281 |
| Cash & equivalents | 6.02 | 6.02 | 5.02 | 8.04 | 10.05 | 10.04 | 15.06 | 24.11 | 18.06 | 21.07 | 15.06 | 22.10 |
| Total Assets | 155 | 167 | 213 | 246 | 346 | 362 | 453 | 554 | 597 | 635 | 779 | 898 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 23.01 | 19.02 | 15.02 | 8.01 | 27.04 | 39.08 | 56.10 | 15.02 | 20.03 | 70.09 | 35.07 | 79.08 |
| Cash from investing activity | −13.99 | −9.99 | −23.01 | −20.99 | −42.99 | −36.01 | −50.01 | −39.01 | −29.97 | −26.99 | −81.92 | −70.96 |
| Cash from financing activity | −9.01 | −9.01 | 7.01 | 16.02 | 17.02 | −3.01 | −1.01 | 32.01 | 4.01 | −41.03 | 42.01 | −1.01 |
| Net cash flow | 1.01 | 0.00 | −1.01 | 2.99 | 2.01 | 0.00 | 4.99 | 8.99 | −4.99 | 1.99 | −4.99 | 7.01 |
| Capex | 17.01 | 9.99 | 17.02 | 20.99 | 44.99 | 37.01 | 50.04 | 40.03 | 31.02 | 31.02 | 83.08 | 77.99 |
| Free cash flow | 5.99 | 8.97 | −1.99 | −13.97 | −15.95 | 1.99 | 5.98 | −23.92 | −9.96 | 43.84 | −47.86 | 6.97 |
| CFO / OP % | 123.0% | 82.1% | 58.1% | 47.0% | 74.1% | 107.1% | 107.1% | 44.1% | 34.1% | 101.1% | 52.1% | 82.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 62 | 66 | 78 | 76 | 78 | 73 | 89 | 78 | 72 | 84 | 86 | 89 |
| Inventory days | 60 | 61 | 67 | 85 | 69 | 99 | 97 | 87 | 79 | 66 | 74 | 86 |
| Days payable | 68 | 66 | 80 | 101 | 80 | 80 | 113 | 88 | 60 | 68 | 67 | 64 |
| Cash conversion cycle | 53 | 61 | 65 | 60 | 67 | 92 | 72 | 77 | 92 | 83 | 94 | 111 |
| Working capital days | −12 | 6 | −38 | 9 | 5 | 10 | 9 | 1 | 17 | 27 | 28 | 32 |
| ROCE % | 14.0% | 19.0% | 23.0% | 22.0% | 22.0% | 11.0% | 19.0% | 14.0% | 17.0% | 17.0% | 18.0% | 20.0% |
For the Jun 2026 quarter, Indo Amines reported sales of ₹373 Cr, up 30.2% year on year and net profit of ₹30.87 Cr, up 6.9% year on year. The operating margin was 14.1%.
Indo Amines' sales for the year to Mar 2026 were ₹1,156 Cr; over the last twelve months they were ₹1,242 Cr.
Net profit for the year to Mar 2026 was ₹78.69 Cr, and ₹81.68 Cr over the last twelve months. Earnings per share over the same trailing period were ₹11.24.
Indo Amines reported borrowings of ₹312 Cr at Mar 2026, against cash and equivalents of ₹22.10 Cr.
Cash from operations was ₹79.08 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹6.97 Cr.